{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "15570426", "DateCompleted": {"Year": "2006", "Month": "09", "Day": "12"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "21"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [{"Year": "2004", "Month": "11", "Day": "27"}], "Journal": {"ISSN": "0172-8172", "JournalIssue": {"Volume": "26", "Issue": "2", "PubDate": {"Year": "2005", "Month": "Dec"}}, "Title": "Rheumatology international", "ISOAbbreviation": "Rheumatol Int"}, "ArticleTitle": "Ameliorative effect of ozone on cytokine production in mice injected with human rheumatoid arthritis synovial fibroblast cells.", "Pagination": {"StartPage": "142", "EndPage": "151", "MedlinePgn": "142-51"}, "Abstract": {"AbstractText": ["Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by invasion of hyperplastic synovial cells and progressive joint destruction. Ozone therapy has been proposed as an immunomodulator and cellular metabolic activator which shows long-term anti-inflammatory effects and serves to reduce further the proinflammatory factors. We purified RA synovial fibroblast cells (RA-SFc) from patients and avoided contaminating macrophages by flow cytometry, then treated them with ozone. Following the observable decreased production of proinflammatory factors TNF-alpha, IL-1beta, and IL-6 from RA-SFc, we infused the cultured RA-SFc into joints of severe combined immunodeficiency mice. The mRNA and protein levels of the RA-SFc exposed to 3% and 5% ozone were the same. As a result, 3% and 5% ozone applied externally ameliorated the inflammatory reaction of RA without toxicity or serious side effects. Therefore, ozone injected into the knees of RA patients could become a valuable treatment, and we confirm the interactive mechanism between ozone and RA-SFc."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Orthopaedics, Johnson General Hospital, 425 Chang Tsau Road, Changhua, Taiwan ROC. jonhsonchangmd@yahoo.com.tw"}], "Identifier": [], "LastName": "Chang", "ForeName": "Johnson D S", "Initials": "JD"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lu", "ForeName": "Hou-Shan", "Initials": "HS"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Chang", "ForeName": "Ye-Fun", "Initials": "YF"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Wang", "ForeName": "David", "Initials": "D"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Rheumatol Int", "NlmUniqueID": "8206885", "ISSNLinking": "0172-8172"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-1"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-6"}, {"RegistryNumber": "0", "NameOfSubstance": "Oxidants, Photochemical"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA, Messenger"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Necrosis Factor-alpha"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Arthritis, Rheumatoid"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": [], "DescriptorName": "Cells, Cultured"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Cytokines"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Fibroblasts"}, {"QualifierName": [], "DescriptorName": "Flow Cytometry"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Injections, Intra-Articular"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Interleukin-1"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Interleukin-6"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, SCID"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Oxidants, Photochemical"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Ozone"}, {"QualifierName": ["metabolism"], "DescriptorName": "RNA, Messenger"}, {"QualifierName": [], "DescriptorName": "Reverse Transcriptase Polymerase Chain Reaction"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Stifle"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Synovial Membrane"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Tumor Necrosis Factor-alpha"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "J Immunol. 1991 Oct 1;147(7):2187-95", "ArticleIdList": ["1918955"]}, {"Citation": "Arthritis Rheum. 1995 Jan;38(1):96-104", "ArticleIdList": ["7818579"]}, {"Citation": "Am Rev Respir Dis. 1989 Feb;139(2):407-15", "ArticleIdList": ["2913889"]}, {"Citation": "J Autoimmun. 2000 Nov;15(3):301-13", "ArticleIdList": ["11040071"]}, {"Citation": "Biochem Biophys Res Commun. 1997 Nov 17;240(2):279-86", "ArticleIdList": ["9388467"]}, {"Citation": "Rheumatol Int. 1991;11(2):45-50", "ArticleIdList": ["1947669"]}, {"Citation": "Am J Pathol. 1988 Jul;132(1):38-48", "ArticleIdList": ["3260752"]}, {"Citation": "Toxicol Mech Methods. 2002;12(1):1-16", "ArticleIdList": ["20597812"]}, {"Citation": "Arthritis Res. 2002;4(2):117-25", "ArticleIdList": ["11879547"]}, {"Citation": "Arthritis Res. 2001;3(1):72-6", "ArticleIdList": ["11178129"]}, {"Citation": "J Appl Physiol (1985). 1986 Apr;60(4):1321-6", "ArticleIdList": ["3084448"]}, {"Citation": "Arch Dermatol Res. 1998 Jul;290(7):360-6", "ArticleIdList": ["9749990"]}, {"Citation": "Arthritis Rheum. 1996 Nov;39(11):1781-90", "ArticleIdList": ["8912499"]}, {"Citation": "Am J Pathol. 1998 Apr;152(4):943-51", "ArticleIdList": ["9546355"]}, {"Citation": "J Clin Invest. 1999 Jul;104(2):137-46", "ArticleIdList": ["10411542"]}, {"Citation": "Mutat Res. 1992 Sep;277(3):221-38", "ArticleIdList": ["1381051"]}, {"Citation": "Clin Exp Immunol. 1988 Sep;73(3):449-55", "ArticleIdList": ["3264773"]}, {"Citation": "Toxicol Appl Pharmacol. 1994 Jul;127(1):27-36", "ArticleIdList": ["8048050"]}, {"Citation": "Am J Pathol. 1996 Nov;149(5):1607-15", "ArticleIdList": ["8909250"]}, {"Citation": "Coll Relat Res. 1983 Mar;3(2):141-55", "ArticleIdList": ["6851475"]}, {"Citation": "Curr Opin Rheumatol. 1997 May;9(3):213-20", "ArticleIdList": ["9204256"]}, {"Citation": "Arthritis Rheum. 1995 Feb;38(2):151-60", "ArticleIdList": ["7848304"]}, {"Citation": "J Rheumatol. 1983 Dec;10(6):845-51", "ArticleIdList": ["6686611"]}, {"Citation": "J Immunol Methods. 2003 Jan 15;272(1-2):125-34", "ArticleIdList": ["12505718"]}, {"Citation": "Methods Enzymol. 1997;287:174-86", "ArticleIdList": ["9330322"]}, {"Citation": "Ann Med. 1997 Dec;29(6):499-507", "ArticleIdList": ["9562516"]}, {"Citation": "Am J Physiol. 1994 Jun;266(6 Pt 1):L612-9", "ArticleIdList": ["8023949"]}, {"Citation": "Clin Exp Rheumatol. 1987 Oct-Dec;5(4):305-8", "ArticleIdList": ["3326690"]}]}], "History": [{"Year": "2004", "Month": "4", "Day": "13"}, {"Year": "2004", "Month": "8", "Day": "7"}, {"Year": "2004", "Month": "12", "Day": "1", "Hour": "9", "Minute": "0"}, {"Year": "2006", "Month": "9", "Day": "13", "Hour": "9", "Minute": "0"}, {"Year": "2004", "Month": "12", "Day": "1", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["15570426", "10.1007/s00296-004-0526-1"]}}], "PubmedBookArticle": []}